Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

FDA approves first drug meant to ease Alzheimer's-linked agitation

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

FDA Approves First Drug for Treating Agitation in Alzheimer's Patients - MedCity News

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

The Madness of Pop Psychiatry - by Nick Jikomes, PhD

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Drug repurposing for Alzheimer's disease: Selective serotonin reuptake inhibitors - Rao - 2020 - Alzheimer's & Dementia - Wiley Online Library

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US